UBS Group initiated coverage on shares of Mettler-Toledo International (NYSE:MTD) in a report published on Tuesday, 99wallstreet.com reports. The firm issued a neutral rating and a $625.00 price target on the medical instruments supplier’s stock.

MTD has been the subject of several other research reports. Morgan Stanley lowered their price target on shares of Mettler-Toledo International from $540.00 to $529.00 and set an equal weight rating for the company in a report on Friday, July 27th. Zacks Investment Research upgraded shares of Mettler-Toledo International from a sell rating to a hold rating in a report on Monday, July 30th. Finally, JPMorgan Chase & Co. upped their target price on shares of Mettler-Toledo International from $550.00 to $600.00 and gave the company a neutral rating in a report on Friday, July 27th. Ten equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has an average rating of Hold and an average target price of $621.82.

NYSE MTD opened at $558.15 on Tuesday. The company has a quick ratio of 1.06, a current ratio of 1.46 and a debt-to-equity ratio of 1.92. Mettler-Toledo International has a 52 week low of $540.24 and a 52 week high of $697.26. The company has a market cap of $15.35 billion, a price-to-earnings ratio of 31.59, a PEG ratio of 2.34 and a beta of 1.08.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 26th. The medical instruments supplier reported $4.65 EPS for the quarter, topping the consensus estimate of $4.58 by $0.07. Mettler-Toledo International had a net margin of 13.52% and a return on equity of 90.80%. The company had revenue of $722.00 million during the quarter, compared to analysts’ expectations of $715.69 million. During the same quarter in the previous year, the business posted $3.92 EPS. The firm’s revenue was up 10.4% on a year-over-year basis. As a group, research analysts expect that Mettler-Toledo International will post 20.15 EPS for the current fiscal year.

In other news, insider La Guerroniere Marc De sold 4,609 shares of the company’s stock in a transaction on Thursday, August 30th. The shares were sold at an average price of $580.37, for a total value of $2,674,925.33. Following the completion of the transaction, the insider now owns 4,609 shares in the company, valued at approximately $2,674,925.33. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider William P. Donnelly sold 500 shares of the company’s stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $570.00, for a total transaction of $285,000.00. Following the completion of the transaction, the insider now owns 1,500 shares of the company’s stock, valued at approximately $855,000. The disclosure for this sale can be found here. In the last 90 days, insiders sold 18,358 shares of company stock valued at $10,744,204. Company insiders own 4.80% of the company’s stock.

Several institutional investors have recently modified their holdings of MTD. Captrust Financial Advisors raised its position in Mettler-Toledo International by 306.7% in the 2nd quarter. Captrust Financial Advisors now owns 183 shares of the medical instruments supplier’s stock valued at $106,000 after purchasing an additional 138 shares during the last quarter. Cornerstone Advisors Inc. raised its position in Mettler-Toledo International by 7,233.3% in the 2nd quarter. Cornerstone Advisors Inc. now owns 220 shares of the medical instruments supplier’s stock valued at $127,000 after purchasing an additional 217 shares during the last quarter. Piedmont Investment Advisors LLC purchased a new stake in Mettler-Toledo International in the 2nd quarter valued at $167,000. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its position in Mettler-Toledo International by 142.3% in the 2nd quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 378 shares of the medical instruments supplier’s stock valued at $219,000 after purchasing an additional 222 shares during the last quarter. Finally, We Are One Seven LLC purchased a new stake in Mettler-Toledo International in the 3rd quarter valued at $365,000. Institutional investors and hedge funds own 92.93% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

See Also: What are trading strategies for the 52-week high/low?

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.